These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 21879841)

  • 21. Synthesis, biological evaluation and 3D QSAR study of 2,4-disubstituted quinolines as anti-tuberculosis agents.
    Patel SR; Gangwal R; Sangamwar AT; Jain R
    Eur J Med Chem; 2015 Mar; 93():511-22. PubMed ID: 25747550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
    Segala E; Sougakoff W; Nevejans-Chauffour A; Jarlier V; Petrella S
    Antimicrob Agents Chemother; 2012 May; 56(5):2326-34. PubMed ID: 22354303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor.
    Huitric E; Verhasselt P; Andries K; Hoffner SE
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4202-4. PubMed ID: 17709466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines.
    Saxena AK; Alam M
    Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimycobacterial activities of novel fluoroquinolones.
    Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diarylquinolines target subunit c of mycobacterial ATP synthase.
    Koul A; Dendouga N; Vergauwen K; Molenberghs B; Vranckx L; Willebrords R; Ristic Z; Lill H; Dorange I; Guillemont J; Bald D; Andries K
    Nat Chem Biol; 2007 Jun; 3(6):323-4. PubMed ID: 17496888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines.
    Balamurugan K; Jeyachandran V; Perumal S; Manjashetty TH; Yogeeswari P; Sriram D
    Eur J Med Chem; 2010 Feb; 45(2):682-8. PubMed ID: 19944499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
    Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
    Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
    Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TMC207 becomes bedaquiline, a new anti-TB drug.
    Palomino JC; Martin A
    Future Microbiol; 2013 Sep; 8(9):1071-80. PubMed ID: 24020736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
    Matteelli A; Carvalho AC; Dooley KE; Kritski A
    Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.
    He C; Preiss L; Wang B; Fu L; Wen H; Zhang X; Cui H; Meier T; Yin D
    ChemMedChem; 2017 Jan; 12(2):106-119. PubMed ID: 27792278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore.
    Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS
    Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diarylquinoline TMC207 for multidrug-resistant tuberculosis.
    Diacon AH; Pym A; Grobusch M; Patientia R; Rustomjee R; Page-Shipp L; Pistorius C; Krause R; Bogoshi M; Churchyard G; Venter A; Allen J; Palomino JC; De Marez T; van Heeswijk RP; Lounis N; Meyvisch P; Verbeeck J; Parys W; de Beule K; Andries K; Mc Neeley DF
    N Engl J Med; 2009 Jun; 360(23):2397-405. PubMed ID: 19494215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.